You are here

Inflectra

Pfizer's Unheralded Franchise That's Worth Billions of Dollars

Motley Fool

Sun, 08/16/20 - 10:44 pm

autoimmune disease

FTC investigates J&J contracts regarding the drugmaker's blockbuster Remicade

Endpoints

Tue, 07/30/19 - 07:59 am

Pfizer lawsuit could clear path for biosimilars

Medical Marketing and Media

Fri, 08/24/18 - 10:36 pm

Judge Denies J&J Motion to Dismiss Pfizer Lawsuit Over Remicade

RAPS.org

Mon, 08/13/18 - 09:43 am

Biosimilars Council Sides with Pfizer in Antitrust Dispute with J&J

JD Supra

Tue, 02/6/18 - 08:40 pm

Pfizer Not Planning US Launch of its Second Remicade Biosimilar Approved by FDA

RAPS.org

Fri, 12/15/17 - 09:36 am

[forum discussion]Pfizer Jumps the Shark over Biosimilar Failure

Cafepharma Message Boards

Tue, 12/12/17 - 11:14 am

Pfizer ready for a fight as biosimilar sales continue to lag

BioPharma Dive

Tue, 10/31/17 - 09:16 pm

[video+transcript]Is This How Drugmakers Will Kill Biosimilars?

Motley Fool

Tue, 10/3/17 - 11:40 am

Pfizer is falling short in a competitive market, Johnson & Johnson says as it hits back at Remicade biosimilar suit

Fierce Pharma

Tue, 09/26/17 - 09:39 pm

This squabble between two big drugmakers could have major implications for the U.S. health care system

Marketwatch

Thu, 09/21/17 - 08:36 am

Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar

First Word Pharma

Wed, 09/20/17 - 11:03 am

Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars

Drug Channels

Wed, 09/20/17 - 09:05 am

FDA Form 483 for Celltrion May Offer a Glimpse Into Limited Uptake for Remicade Biosimilar

RAPS.org

Fri, 09/8/17 - 09:28 am

How did Johnson & Johnson beat back Remicade's biosim? Call it the art of the deal

Fierce Pharma

Thu, 07/20/17 - 11:18 am

Here's Why the Best Is Yet to Come for Pfizer Inc.

Motley Fool

Mon, 05/15/17 - 08:59 am

J&J's Remicade sees 'very little' biosim erosion, but payers are sticking it to Xarelto

Fierce Pharma

Tue, 04/18/17 - 09:03 pm

Pfizer and Celltrion Seek Biosimilar Interchangeability for Crohn’s Disease Drug

Xtalks

Mon, 02/27/17 - 10:02 pm

Crohn's Disease

Pfizer, Celltrion pushing for interchangeability with Inflectra

BioPharma Dive

Thu, 02/23/17 - 09:11 am

Pfizer's New Biosimilar Is Off and Running

Motley Fool

Sat, 02/4/17 - 10:00 am

rheumatoid arthritis

Pages